Literature DB >> 29275954

Epidemiology of CF: How registries can be used to advance our understanding of the CF population.

Abaigeal D Jackson1, Christopher H Goss2.   

Abstract

Cystic fibrosis (CF) registries work by bringing patient data together from specialist CF centres and accumulating data on a relatively rare condition over patients' lifetimes. In this review, we examine the origin of national CF registries, the use of registries for monitoring the health of the population, the power of conducting longitudinal analysis of registry data, knowledge gleaned from changing demographics, the evolving area of international comparisons of registries, strategies for sustaining registries and CF registries of the future. Examples of research undertaken using registry data and routinely reported CF registry statistics from across the world are provided. The application, utility and challenges facing CF registries in the future are discussed.
Copyright © 2017 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Epidemiology; Patient registry; Registries

Mesh:

Year:  2017        PMID: 29275954     DOI: 10.1016/j.jcf.2017.11.013

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  23 in total

1.  Human epididymis protein 4 (HE4) protects against cystic pulmonary fibrosis associated-inflammation through inhibition of NF-κB and MAPK singnaling.

Authors:  Jinli Wang; Hongyang Zhao; Fenfen Xu; Piaopiao Zhang; Yuan Zheng; Nan Jia
Journal:  Genes Genomics       Date:  2019-06-04       Impact factor: 1.839

2.  Inhaled antibiotic use is associated with Scedosporium/Lomentospora species isolation in cystic fibrosis.

Authors:  Gina Hong; Noah Lechtzin; Denis Hadjiliadis; Steven M Kawut
Journal:  Pediatr Pulmonol       Date:  2018-12-14

3.  Seasonal variation of lung function in cystic fibrosis: longitudinal modeling to compare a Midwest US cohort to international populations.

Authors:  Emrah Gecili; Cole Brokamp; Anushka Palipana; Rui Huang; Eleni-Rosalina Andrinopoulou; Teresa Pestian; Erika Rasnick; Ruth H Keogh; Yizhao Ni; John P Clancy; Patrick Ryan; Rhonda D Szczesniak
Journal:  Sci Total Environ       Date:  2021-03-01       Impact factor: 10.753

Review 4.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

Review 5.  On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis.

Authors:  Marjolein Ensinck; Angélique Mottais; Claire Detry; Teresinha Leal; Marianne S Carlon
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

6.  Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.

Authors:  Alex H Gifford; Julie L Sanville; Meghana Sathe; Sonya L Heltshe; Christopher H Goss
Journal:  Pediatr Pulmonol       Date:  2021-04-26

7.  Interventions for promoting participation in shared decision-making for children and adolescents with cystic fibrosis.

Authors:  Helen Malone; Susan Biggar; Sheila Javadpour; Zai Edworthy; Greg Sheaf; Imelda Coyne
Journal:  Cochrane Database Syst Rev       Date:  2019-05-23

8.  Dynamic Prediction of Survival in Cystic Fibrosis: A Landmarking Analysis Using UK Patient Registry Data.

Authors:  Ruth H Keogh; Shaun R Seaman; Jessica K Barrett; David Taylor-Robinson; Rhonda Szczesniak
Journal:  Epidemiology       Date:  2019-01       Impact factor: 4.822

9.  Mortality Due to Cystic Fibrosis over a 36-Year Period in Spain: Time Trends and Geographic Variations.

Authors:  Ana Villaverde-Hueso; Germán Sánchez-Díaz; Francisco J Molina-Cabrero; Elisa Gallego; Manuel Posada de la Paz; Verónica Alonso-Ferreira
Journal:  Int J Environ Res Public Health       Date:  2019-01-04       Impact factor: 3.390

10.  Comparison of Physical Activity and Sedentary Behaviour between Schoolchildren with Cystic Fibrosis and Healthy Controls: A Gender Analysis.

Authors:  Alexandra Valencia-Peris; Jorge Lizandra; Irene Moya-Mata; Fernando Gómez-Gonzalvo; Silvia Castillo-Corullón; Amparo Escribano
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.